Corporate Profile
Galera Therapeutics is aiming to transform radiotherapy for patients with cancer by developing novel therapies to reduce radiotherapy-induced toxicities and improve the anti-cancer efficacy of radiation.
NASDAQ: GRTX
$2.59
-0.04
(-1.52%)
Day High: $2.67
Day Low: $2.53
Volume: 231,878 Jun 27, 2023 11:46 AM EDT
Data Provided by Refinitiv.
Minimum 15 minutes delayed.